Quick answers
- What is Vistogard?
- Vistogard is a brand name of Uridine triacetate, a prescription medicine. The FDA NDC Directory lists 1 Vistogard product in 1 strength and form.
- Who makes Vistogard?
- BTG Intl holds the FDA application for Vistogard (NDA208159, approved December 11, 2015).
- Is there a generic or store brand of Vistogard?
- Yes. The FDA NDC Directory lists 1 other product with the same active ingredients, strength and form as a Vistogard product. Ask your pharmacist whether one is right for you.
- Has Vistogard been recalled?
- No recall linked to Vistogard products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Vistogard is
Each Vistogard product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Uridine triacetate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| uridine triacetate 95.1% granule (oral) | Vistogard | 1 product, 1 company | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Uridine triacetate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA208159 | BTG Intl | December 11, 2015 | 1 |
Companies that list Vistogard
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Vistogard products.
- BTG International Inc1 product
Recalls
No recall linked to Vistogard products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.